This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $5,921.15 contract is for the provision of 4,557,474,207 units of the pharmaceutical drug TRINTELLIX 10 MG TABLET 30S. This delivery order contract does not have a set-aside designation and supports the DLA Troop Support Medical's mission of providing...
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product, with a potential value of $6,098.66 and a completion date of March 30, 2022. Dakota Drug, Inc. serves as a prime contractor providing a range of pharmaceutical...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRINTELLIX 10 MG TABLET 30S. This award, valued at $7,220.95, supports DLA Troop Support Medical's mission of providing comprehensive medical supply chain operations for the U.S. Armed Forces. Dakota Drug, Inc. has a long-standing history as a prime contractor to the federal government, particularly...
The federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical under the ECAT Generation V Program. The firm fixed-price delivery order, valued at $1,291.82, is for the supply of the prescription drug Trulicity (1.5 mg/0.5 ml pen) with an ultimate completion date of August 22, 2024. This contract is not set aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,311.87, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,312.08 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical under the ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $3,039.84 and a period of performance through October 21, 2024. Dakota Drug, Inc. is also the holder of a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,479.21 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, with a performance period through August 15, 2024. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $5,011.42 firm fixed-price contract has a period of performance through November 8, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,232.70 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. This contract is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription pharmaceutical product. The contract has an ultimate completion date of August 8, 2024 and was awarded on August 7, 2024. Dakota Drug, Inc. has a significant Indefinite Delivery...